BNP PARIBAS FINANCIAL MARKETS - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 16 filers reported holding PTC THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$2,006,360,000
-0.9%
2,000,0000.0%0.00%0.0%
Q1 2022$2,025,000,000
-2.6%
2,000,0000.0%0.00%0.0%
Q4 2021$2,080,000,000
-28.1%
2,000,000
-22.6%
0.00%
-50.0%
Q1 2020$2,891,555,0002,585,0000.01%
Other shareholders
PTC THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 14,800,000$15,353,0001.33%
WOLVERINE ASSET MANAGEMENT LLC 25,939,000$26,873,0000.37%
FARALLON CAPITAL MANAGEMENT LLC 24,130,000$24,718,0000.19%
CSS LLC/IL 2,000,000$2,072,0000.12%
CAPSTONE INVESTMENT ADVISORS, LLC 9,500,000$9,909,0000.09%
Allianz Asset Management GmbH 31,695,000$32,786,0000.03%
AQR Arbitrage LLC 1,500,000$1,565,0000.02%
D. E. Shaw & Co., Inc. 9,443,000$9,776,0000.01%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 9,300,000$9,677,487,0000.01%
Citadel Advisors 13,000,000$13,479,0000.01%
View complete list of PTC THERAPEUTICS INC shareholders